Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 7 min ago

Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer

Tue, 01/14/2014 - 13:00
COLUMBIA, Md.--(Healthcare Sales & Marketing Network)--Osiris Therapeutics, Inc. (OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets is pleased to anno...
Biopharmaceuticals, Regenerative Medicine, Personnel
Osiris Therapeutics, stem cell, remestemcel, Grafix

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

Tue, 01/14/2014 - 12:53
CAMBRIDGE, Mass. & TEL AVIV, Israel--(Healthcare Sales & Marketing Network)--ARIAD Pharmaceuticals, Inc. (ARIA) and Medinol, Ltd. today announced the initiation of two registration trials of Medinol’s NIRsupremeTM Ridaforolimus-Eluting Coronary Stent Syste...
Devices, Interventional Cardiology
ARIAD Pharmaceuticals, Medinol, NIRsupreme, Ridaforolimus, drug eluting stent

Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units

Tue, 01/14/2014 - 12:48
DUBLIN, Jan. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Actavis plc (ACT), a leading global specialty pharmaceutical company, today announced an updated business structure for its U.S. Specialty Brands business designed to maximize the Company'...
Biopharmaceuticals, Urology, Gastroenterology, Personnel
Actavis, Rapaflo, Androderm, Enablex, Delzicol, Asacol

Caliber Imaging and Diagnostics Receives $1.4 Million Order for VivaScope(R) Systems From European Distributor MAVIG GmbH

Tue, 01/14/2014 - 12:43
Expects to Deliver Devices in the First Half of 2014 BOSTON and ROCHESTER, N.Y., Jan. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Caliber Imaging & Diagnostics (LCDX), formerly Lucid, Inc., announces receipt of $1.4 million in orders for VivaS...
Devices, Oncology, Distribution
Caliber Imaging & Diagnostics, MAVIG GmbH, VivaScope

Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors

Tue, 01/14/2014 - 12:36
“Go-it-alone” option favored to maximize long term value and reach critical mass in the US PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext : IPN ; ADR : IPSEY) today announced its decision to set up its own oncology team to commercialize ...
Biopharmaceuticals, Oncology
Ipsen, Somatuline, lanreotide, neuroendocrine tumors

Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America

Tue, 01/14/2014 - 12:28
The intended indication of Sativex® is the treatment of spasticity due to multiple sclerosis Sativex® a companion drug to Dysport® in neurology LONDON & PARIS--(Healthcare Sales & Marketing Network)--Ipsen (IPN.PA) (Euronext: IPN; ADR: IP...
Biopharmaceuticals, Neurology, Distribution
Ipsen, GW Pharmaceuticals, cannabinoid, Sativex, spasticity

Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’

Tue, 01/14/2014 - 04:00
Brazil Acquisition, China Joint Venture Enable Company to Address Underserved Markets, Expand Patient Access to Care DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Moving decisively to accelerate a key component of its emerging markets strate...
Devices, Surgery, Mergers & Acquisitions
Covidien, electrosurgical generator, surgical stapler

Align Technology Promotes Raphael Pascaud to Vice President International

Mon, 01/13/2014 - 20:42
SAN JOSE, CA--(Healthcare Sales & Marketing Network) - Align Technology, Inc. (NASDAQ: ALGN) today announced the promotion of Raphael S. Pascaud to vice president international, reporting directly to Thomas M. Prescott, Align Technology president and CEO. ...
Devices, Dental, Personnel
Align Technology, Invisalign

Pyng Medical Signs Nine New Medical Device Distributors

Mon, 01/13/2014 - 20:40
Distributors to Market Pyng's Trauma and Resuscitation Products to the United States Civilian Market VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and res...
Devices, Distribution
Pyng Medical, sternal intraosseous

Mauna Kea Technologies Announces Centers for Medicare and Medicaid Services Set New Physician Payments for Upper GI Endoscopy with Cellvizio(R) Optical Endomicroscopy

Mon, 01/13/2014 - 20:36
Physicians in the United States to be paid for procedures involving Cellvizio based on published rates included in 2014 National Average Physician Fees ATLANTA, Ga.--(Healthcare Sales & Marketing Network)--The U.S. Centers for Medicare & Medicaid Servic...
Devices, Gastroenterology, Reimbursement
Mauna Kea Technologies, Cellvizio, Optical Endomicroscopy, Endoscopy

KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014

Mon, 01/13/2014 - 20:34
Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel for Stine Seed Company, Added to KemPharm's Board CORALVILLE, Iowa, Jan. 13, 2014 -- (Healthcare Sales & Marketing Network) -- KemPharm, Inc., a clinical...
Biopharmaceuticals, Personnel
KemPharm, Ligand Activated Therapy

Seattle Genetics Appoints John A. Orwin to Board of Directors

Mon, 01/13/2014 - 20:31
BOTHELL, Wash.--(Healthcare Sales & Marketing Network)--Seattle Genetics, Inc. (SGEN) announced today that John A. Orwin has been appointed to the company’s Board of Directors. Mr. Orwin is a biotechnology and pharmaceutical industry veteran with nearly 25...
Biopharmaceuticals, Drug Delivery, Oncology, Personnel
Seattle Genetics, antibody-drug conjugate, ADCETRIS, brentuximab

RTI Surgical(TM) Announces Agreement to Supply Complete Surgical Specialties Portfolio to Yankee Alliance Members

Mon, 01/13/2014 - 20:28
ALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical Inc. (RTI) (RTIX), a leading global surgical implant company, announced a new agreement with Yankee Alliance, a group purchasing organization with more than 14,700 members. The agreement c...
Devices, Surgery, Group Purchasing, Distribution
RTI Surgical, Yankee Alliance, hernia repair

Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective

Mon, 01/13/2014 - 20:25
MINNEAPOLIS, Jan. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Vascular Solutions, Inc. (VASC) announced today that the U.S. Court of Appeals for the Federal Circuit has refused to grant an interim stay during appeal of the injunction issued by th...
Devices, Interventional, Litigation
Vascular Solutions, Boston Scientific, Guidezilla, guide extension catheter

LabCorp to Offer New FDA approved Breast Cancer Prognostic Test

Mon, 01/13/2014 - 20:23
BURLINGTON, N.C.--(Healthcare Sales & Marketing Network)--Laboratory Corporation of America® Holdings (LabCorp®) (LH) announced today the launch of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay, an FDA approved breast cancer prognosti...
Diagnostics, Oncology, Product Launch
Laboratory Corporation of America, LabCorp, Prosigna, Breast Cancer

OvaScience Provides Update on Pipeline Advancements and Commercial Plans; New Potential Fertility Treatment OvaPrime(SM) to Launch in 2015

Mon, 01/13/2014 - 20:20
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--OvaScienceSM, (OVAS), a life sciences company focused on the discovery, development and commercialization of female fertility treatments, today provided an update on its product pipeline and commerc...
OvaScience, EggPC, OvaTure, OvaPrime, in vitro fertilization

CorMedix Expands Neutrolin(R) Sales with Middle East Distribution Agreements

Mon, 01/13/2014 - 20:18
Company Establishes Sales and Marketing Oversight Committee for Neutrolin Commercialization BRIDGEWATER, N.J., Jan. 13, 2014 -- (Healthcare Sales & Marketing Network) -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and...
Biopharmaceuticals, Devices, Distribution
CorMedix, Neutrolin, catheter lock solution, catheter lock

Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma

Mon, 01/13/2014 - 20:15
Expects to Complete Application in First Half of 2014 WHITEHOUSE STATION, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, said today it has started a rolling submission to the U.S. Food and ...
Biopharmaceuticals, Oncology, FDA
Merck, anti-PD-1 immunotherapy, immunotherapy, melanoma

Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders

Mon, 01/13/2014 - 16:39
Key Appointments Position Company to Further Advance Development of Lead Compound Onapristone and Companion Diagnostic FLEMINGTON, N.J., Jan. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Arno Therapeutics, Inc. (ARNI), a clinical stage biopharm...
Biopharmaceuticals, Oncology, Personnel
Arno Therapeutics, Onapristone

Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness

Mon, 01/13/2014 - 16:36
Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments Investor conference call to be held today, January 13 at 8:30 AM EST/1:30 PM GMT DUBLIN, Jan. 13, 2014 -- (Healthcare Sales & Marketing Ne...
Biopharmaceuticals, Acquisitions
Jazz Pharmaceuticals, Aerial Biopharma, daytime sleepiness

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong